The Federal Capital Territory Administration (FCTA) has introduced High-Intensity Focused Ultrasound (HIFU) technology at Wuse District Hospital as part of efforts to improve the management of uterine fibroids, pre-cancerous cervical conditions and women’s reproductive health.
Donation and Milestone
The HIFU machine, donated by Nordica Fertility Centre during the Renewed Hope Reproductive Health Week 2026, was described by stakeholders as a significant milestone in expanding access to innovative, minimally invasive healthcare services for women in the FCT.
How HIFU Works
HIFU is a non-invasive outpatient procedure that uses focused ultrasound waves to target and destroy fibroid tissue while preserving the uterus. According to experts, the technology generates precise, localised heat that shrinks fibroids and provides lasting symptom relief without surgery, incisions or general anaesthesia.
Uterine fibroids remain a major health concern for many women, often leading to excessive bleeding, pelvic pain, infertility, pregnancy complications and, in severe cases, hysterectomy. However, advances in medical technology have created alternatives that offer effective treatment while preserving reproductive potential.
Experts at the event explained that HIFU destroys targeted tissue by converting focused ultrasound waves into thermal energy, eliminating the need for surgical intervention and significantly reducing hospital stay and recovery time.
Government and Expert Perspectives
Speaking at the event, the Mandate Secretary of the Health Services and Environment Secretariat (HSES), Dr Adedolapo Fasawe, said uterine fibroids remain one of the most common reproductive health conditions affecting women.
According to her, the condition often results in excessive bleeding, pain, infertility, pregnancy complications, reduced productivity and psychological distress.
Fasawe noted that many women continue to delay seeking treatment because of fear, misinformation, stigma, financial constraints and limited awareness of available treatment options.
To encourage access to the service, the FCT Health Secretariat announced that the first 100 eligible beneficiaries would receive HIFU treatment free of charge.
She described the donation as a remarkable example of private-sector support for public healthcare and said it would strengthen ongoing efforts to reduce cancer-related deaths and improve access to quality reproductive health services across the FCT.
Nordica Fertility Centre's Commitment
Chairman of Nordica Fertility Centre, Dr Abayomi Ajayi, reaffirmed the organisation’s commitment to promoting sustainable healthcare innovations in Nigeria.
He disclosed that although discussions had focused on more than 650 women successfully treated with HIFU, the actual number of patients who had undergone the procedure exceeded 940.
According to him, the technology has demonstrated significant potential in improving treatment outcomes for women with fibroids while reducing the burden associated with conventional surgical procedures.
Specialist Insights on Fibroids
Consultant gynaecologist and HIFU specialist, Dr John Bakut, said fibroids contribute substantially to physical discomfort, psychosocial stress and economic losses resulting from reduced productivity and healthcare expenditure.
He stressed that while HIFU offers a promising treatment option, not every fibroid case is suitable for the procedure, noting that careful patient selection remains essential to achieving optimal outcomes.
